Clinical consequences of such malnutrition can lead to impaired muscle function, decreased wound healing, altered ventilatory response, and abnormal immune function [54]
Diabetes 2023;72(Supplement 1):51OR
GLP-1 agonists benefit MASH patients by reducing liver fat, decreasing inflammation, and hence improving liver tissue structure, potentially slowing the progression of the disease
Both GLP-1 and its homolog GLP-2 concentration-dependently enhance enteric neuronal survival, synergistically preserving the integrity of the ENS structure
Algunos agonistas especficos (liraglutida, semaglutida inyectable y dulaglutida) han demostrado reducir eventos cardiovasculares mayores en ensayos clnicos
This is because fiber takes longer to digest than sugar, which can delay the release of GLP-1